Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-044917
Filing Date
2023-12-14
Accepted
2023-12-14 17:16:03
Documents
1
Period of Report
2023-12-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4142
  Complete submission text file 0001493152-23-044917.txt   5620
Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139
Business Address
Lewis-Hall Freda C (Reporting) CIK: 0001437909 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41245 | Film No.: 231487963

Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Issuer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations